Jonathan Mordis is CEO of the Chemistry RX platform, which includes four 503A compounding pharmacies throughout the USA. Jonathan is a 3rd generation pharmacist who has practiced in many different aspects of pharmacy throughout his career. In 2011, he became immersed in compounding pharmacy services after witnessing the struggles many patients experienced when they suffered from rare and debilitating conditions, and those for which commercially available products did not provide adequate therapies for. He joined Chemistry RX in 2022 as COO and moved into the CEO role later that year. His pharmacy knowledge includes clinical patient care, pharmacy operations, and provider and institutional hospital business development. Jonathan brings his mission of “no patient left behind” to every organization he has ever been a part of. This mission allows him to build teams that provide superior benefit to critically ill patients and allows these patients to not be burdened with the logistics and availability of the best treatments for their conditions. In his free time, he enjoys exercising, the outdoors, and spending time with his 3 kids.
Past Expert Series Presentations
